176 related articles for article (PubMed ID: 26693761)
1. Gaviscon and domperidon responsive apnea episodes associated with gastro-esophageal reflux disease in twins.
Bilgin H; Eren A; Kara S
Asia Pac J Clin Nutr; 2015; 24(4):753-5. PubMed ID: 26693761
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.
Corvaglia L; Aceti A; Mariani E; De Giorgi M; Capretti MG; Faldella G
Aliment Pharmacol Ther; 2011 Feb; 33(4):466-70. PubMed ID: 21158879
[TBL] [Abstract][Full Text] [Related]
3. Gaviscon for gastro-oesophageal reflux in infants: a poorly effective treatment?
Cresi F; Savino F; Marinaccio C; Silvestro L
Arch Dis Child; 2006 Jan; 91(1):93. PubMed ID: 16371388
[No Abstract] [Full Text] [Related]
4. Pharmacological treatment of children with gastro-oesophageal reflux.
Tighe M; Afzal NA; Bevan A; Hayen A; Munro A; Beattie RM
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008550. PubMed ID: 25419906
[TBL] [Abstract][Full Text] [Related]
5. Sodium Alginate (Gaviscon®) does not reduce apnoeas related to gastro-oesophageal reflux in preterm infants.
Corvaglia L; Spizzichino M; Zama D; Aceti A; Mariani E; Legnani E; Faldella G
Early Hum Dev; 2011 Dec; 87(12):775-8. PubMed ID: 21696897
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of gastro-esophageal reflux using a potable gaviscon suspension].
Guerre J; Neuman M; Bouchet J
Med Chir Dig; 1982; 11(4):289-95. PubMed ID: 6287126
[No Abstract] [Full Text] [Related]
7. [Treatment with sodium alginate of gastroesophageal reflux disease in childhood: efficacy and tolerance assessment].
Maestri L
Pediatr Med Chir; 2001; 23(3-4):187-9. PubMed ID: 11723856
[TBL] [Abstract][Full Text] [Related]
8. [Can acid pocket-targeting alginate-antacid (Gaviscon Double Action) relieve upper gastrointestinal symptoms in gastro-oesophageal reflux disease?].
Kim SE; Park MI
Korean J Gastroenterol; 2014 Jun; 63(6):386-8. PubMed ID: 25097964
[No Abstract] [Full Text] [Related]
9. A comparison between cisapride and Gaviscon with Carobel in the treatment of gastro-oesophageal reflux in infancy.
Greally P; Hampton FJ; MacFadyen UM; Simpson H
Ir Med J; 1992; 85(4 Suppl):14. PubMed ID: 1490841
[No Abstract] [Full Text] [Related]
10. Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pH.
Del Buono R; Wenzl TG; Ball G; Keady S; Thomson M
Arch Dis Child; 2005 May; 90(5):460-3. PubMed ID: 15851425
[TBL] [Abstract][Full Text] [Related]
11. [Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].
Uspenskiĭ IuP; Pakhomova IG; Bubiakina VN
Eksp Klin Gastroenterol; 2008; (1):96-101. PubMed ID: 19145860
[No Abstract] [Full Text] [Related]
12. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
Mandel KG; Daggy BP; Brodie DA; Jacoby HI
Aliment Pharmacol Ther; 2000 Jun; 14(6):669-90. PubMed ID: 10848650
[TBL] [Abstract][Full Text] [Related]
13. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.
Thomas E; Wade A; Crawford G; Jenner B; Levinson N; Wilkinson J
Aliment Pharmacol Ther; 2014 Mar; 39(6):595-602. PubMed ID: 24471505
[TBL] [Abstract][Full Text] [Related]
14. [Using gaviscon preparation for relief of esophageal, extraesophageal syndromes and functional dyspepsia in elderly patients with GERD].
Onuchina EV; Brikova SI; Tsukanov VV
Eksp Klin Gastroenterol; 2010; (10):80-6. PubMed ID: 21434379
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux.
Ward AE
Br J Clin Pract Suppl; 1989 Feb; 66():52-5; discussion 61-4. PubMed ID: 2556176
[No Abstract] [Full Text] [Related]
16. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.
Sweis R; Kaufman E; Anggiansah A; Wong T; Dettmar P; Fried M; Schwizer W; Avvari RK; Pal A; Fox M
Aliment Pharmacol Ther; 2013 Jun; 37(11):1093-102. PubMed ID: 23600790
[TBL] [Abstract][Full Text] [Related]
17. [Influence of sodium alginate on the intestinal transit in low birth weight newborn infants].
Chouraqui JP; Morer I; Renard P; Bielsky MC; Richard-Berthe C; Rambaud P
Pediatrie; 1993; 48(6):473-7. PubMed ID: 8247649
[TBL] [Abstract][Full Text] [Related]
18. [Gastroesophageal reflux in premature: a case report].
Ndour D
Pan Afr Med J; 2016; 25():243. PubMed ID: 28293359
[TBL] [Abstract][Full Text] [Related]
19. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
[TBL] [Abstract][Full Text] [Related]
20. [Heartburn and regurgitation in pregnancy. Efficacy and innocuousness of treatment with Gaviscon suspension].
Uzan M; Uzan S; Sureau C; Richard-Berthe C
Rev Fr Gynecol Obstet; 1988; 83(7-9):569-72. PubMed ID: 2848305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]